Last updated on January 2020

An Exploratory Maintenance Trial of BI 655064 in Patients With Lupus Nephritis


Brief description of study

The main objectives of this trial are to evaluate the long term efficacy and safety of different doses of BI 655064 versus placebo as add-on therapy to Standard of Care (SOC) during maintenance therapy for lupus nephritis.

Detailed Study Description

Initially planned participating countries:

Argentina, Australia, Canada, Colombia, Czech Republic, France, Germany, Greece, Hong Kong, Italy, Japan, Republic of Korea, Malaysia, Mexico, Philippines, Poland, Portugal, Serbia, Spain, Taiwan, Thailand, United Kingdom, United States

Clinical Study Identifier: NCT03385564

Find a site near you

Start Over

Princess Alexandra Hospital

Woolloongabba, Australia
2.62miles
  Connect »